Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19

The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising treatment comprising medication or vaccination till date. The discovery of antiviral drug is of immense importance in the existing spread of novel coronavirus. The goal of the present study was to evolve an opp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Abdellatiif Magda H., Ali Amena, Ali Abuzer, Hussien Mostafa A.
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
moe
Acceso en línea:https://doaj.org/article/6b2a4c7c5e3943838b978f6fccbc2b27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b2a4c7c5e3943838b978f6fccbc2b27
record_format dspace
spelling oai:doaj.org-article:6b2a4c7c5e3943838b978f6fccbc2b272021-12-05T14:10:43ZComputational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-192391-542010.1515/chem-2021-0024https://doaj.org/article/6b2a4c7c5e3943838b978f6fccbc2b272021-03-01T00:00:00Zhttps://doi.org/10.1515/chem-2021-0024https://doaj.org/toc/2391-5420The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising treatment comprising medication or vaccination till date. The discovery of antiviral drug is of immense importance in the existing spread of novel coronavirus. The goal of the present study was to evolve an opposite antiviral drug against the novel COVID-19 virus. A directly succeeding perspective would be to use the prevailing influential drugs from several antimicrobial and chemotherapeutic agents. The encouraging approach is to identify promising drug molecules and compounds through virtual screening via molecular docking of FDA-approved drugs and some previously synthesized pyridone and coumarin derivatives for probable therapeutic outcome. In this conceptual milieu, an effort has been made to propose a computational in silico relationship among FDA-approved drugs and coronavirus-associated receptors and proteins. The study results were evaluated on the basis of a dock score by using molecular operating environment. Out of 15 compounds screened, the compounds with the best docking scores toward their targets was 3d. Therefore, compound 3d deserves further investigations and clinical trials as a possible therapeutic inhibitor of the COVID-19 caused by the novel SARS-CoV-2.Abdellatiif Magda H.Ali AmenaAli AbuzerHussien Mostafa A.De Gruyterarticlemoemolecular dockingcovid-19pyridonescoumarinChemistryQD1-999ENOpen Chemistry, Vol 19, Iss 1, Pp 245-264 (2021)
institution DOAJ
collection DOAJ
language EN
topic moe
molecular docking
covid-19
pyridones
coumarin
Chemistry
QD1-999
spellingShingle moe
molecular docking
covid-19
pyridones
coumarin
Chemistry
QD1-999
Abdellatiif Magda H.
Ali Amena
Ali Abuzer
Hussien Mostafa A.
Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
description The COVID-19 outbreak is a matter of concern worldwide due to unavailability of promising treatment comprising medication or vaccination till date. The discovery of antiviral drug is of immense importance in the existing spread of novel coronavirus. The goal of the present study was to evolve an opposite antiviral drug against the novel COVID-19 virus. A directly succeeding perspective would be to use the prevailing influential drugs from several antimicrobial and chemotherapeutic agents. The encouraging approach is to identify promising drug molecules and compounds through virtual screening via molecular docking of FDA-approved drugs and some previously synthesized pyridone and coumarin derivatives for probable therapeutic outcome. In this conceptual milieu, an effort has been made to propose a computational in silico relationship among FDA-approved drugs and coronavirus-associated receptors and proteins. The study results were evaluated on the basis of a dock score by using molecular operating environment. Out of 15 compounds screened, the compounds with the best docking scores toward their targets was 3d. Therefore, compound 3d deserves further investigations and clinical trials as a possible therapeutic inhibitor of the COVID-19 caused by the novel SARS-CoV-2.
format article
author Abdellatiif Magda H.
Ali Amena
Ali Abuzer
Hussien Mostafa A.
author_facet Abdellatiif Magda H.
Ali Amena
Ali Abuzer
Hussien Mostafa A.
author_sort Abdellatiif Magda H.
title Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
title_short Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
title_full Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
title_fullStr Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
title_full_unstemmed Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19
title_sort computational studies by molecular docking of some antiviral drugs with covid-19 receptors are an approach to medication for covid-19
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/6b2a4c7c5e3943838b978f6fccbc2b27
work_keys_str_mv AT abdellatiifmagdah computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19
AT aliamena computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19
AT aliabuzer computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19
AT hussienmostafaa computationalstudiesbymoleculardockingofsomeantiviraldrugswithcovid19receptorsareanapproachtomedicationforcovid19
_version_ 1718371790465531904